Renaissance Technologies
LABD icon

Renaissance Technologies’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Renaissance Technologies’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-787
Closed -$470K – 3570
2020
Q3 		$470K Buy
+787
New +$508K ﹤0.01% 2830

Other funds holding LABD

BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies's LABD Position: Q4 2020 in Review

Renaissance Technologies sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q4 2020, closing a stake of 787 shares — an estimated $470K sold.

Renaissance Technologies first reported a position in LABD in Q3 2020 and held it in 1 quarter. The position peaked at $470K in Q3 2020. 11 funds tracked by Wall St. Rank hold LABD as of Q4 2020.

  • Renaissance Technologies reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q4 2020 after selling out during the quarter.
  • Renaissance Technologies sold 787 Direxion Daily S&P Biotech Bear 3X ETF shares in Q4 2020, an estimated $470K.
  • Renaissance Technologies first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q3 2020 and held it in 1 quarter.
  • Renaissance Technologies's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $470K in Q3 2020.
  • 11 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q4 2020.

Based on Renaissance Technologies's 13F filing for Q4 2020, filed 10 Feb 2021.